Neurogene Cash Flow Statement (2018-2025) | NGNE

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income 3.07M-14.73M-4.83M-59.52M-8.36M-12.26M-11.86M-14.57M-13.97M-17.06M-18.63M-20.36M-19.66M-22.79M-23.23M-21.10M
Share-based Compensation 1.31M1.50M1.00M0.84M1.08M0.79M5.15M0.67M0.68M1.02M1.69M0.29M0.35M1.04M2.31M2.47M2.49M4.05M3.41M3.37M
Gains from Sales and Divestitures 0.01M0.01M0.04M
Gains from Investment Securities 2.78M0.20M3.36M0.18M-0.01M0.53M0.67M5.34M5.61M6.77M0.01M0.20M0.06M0.01M0.01M0.01M
Asset Writedowns and Impairment 0.10M0.09M
Non-cash Items 1.12M1.18M1.25M1.20M1.08M40.43M66.95M42.14M
Cash from Operations -15.59M9.18M-15.39M-9.78M-2.76M-1.47M-6.53M-4.64M-6.44M-13.60M-9.30M-11.60M-16.92M-21.70M-15.84M-15.56M-17.50M-20.80M-19.44M-19.51M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.02M0.03M0.02M0.11M0.53M0.01M0.01M0.01M0.08M0.45M0.02M0.01M0.96M1.75M0.01M0.01M
Amortization of Deferred Charges 0.02M0.03M0.02M0.53M0.00M0.25M
Depreciation & Amortization (CF) 0.04M0.04M0.10M0.16M0.17M0.81M0.80M0.80M0.85M0.81M0.80M0.80M0.79M0.75M0.80M0.80M
Change in Working Capital
Change in Account Payables 0.82M0.03M0.66M-0.84M0.14M0.23M-0.03M-0.42M1.69M-0.97M-0.50M
Change in Accured Expenses -1.63M3.96M-2.64M-6.16M-1.30M-2.50M-0.04M1.82M0.88M-2.44M1.16M1.38M-3.66M-4.88M0.21M2.64M-0.74M-2.20M2.17M0.36M
Investing Activities
Capital Expenditures 0.04M0.03M-0.02M0.78M0.11M0.03M0.08M0.08M0.13M0.14M0.38M0.18M0.10M0.78M0.15M0.13M
Change in Acquisitions & Divestments 30.00M23.00M3.00M5.00M30.00M19.50M8.75M15.75M44.70M68.00M99.50M
Cash from Investing Activities 29.96M22.97M3.02M-0.78M-0.11M-0.03M-0.08M-0.08M25.83M29.93M-23.61M-28.97M-102.62M-45.05M7.45M21.99M
Financing Activities
Other financing activities 0.10M1.86M-1.96M4.29M0.17M
Debt Issuance and Repayment
Long-Term Debt Repayments 0.00M0.00M0.02M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Capital Stock
Shares Issued 0.20M0.40M81.00M3.39M0.11M0.02M0.04M92.18M0.63M0.41M0.14M188.40M0.02M0.07M9.71M
Misc.
Cash from Financing Activities 0.20M0.40M-0.02M-0.00M-0.00M-0.00M0.04M82.20M3.39M0.11M-0.09M-1.84M94.30M-6.52M0.40M0.13M190.06M0.00M0.05M9.71M
Exchange Rate Effect 0.01M-0.03M-0.00M-0.03M-0.00M0.00M0.01M0.00M-0.01M0.01M
Change in Cash 14.58M32.52M-12.40M-9.80M-2.76M-1.47M-6.39M76.79M-3.17M-13.48M-9.49M-13.49M103.16M1.76M-39.11M-44.40M69.95M-65.81M-11.96M12.19M
Free Cash Flow -15.63M9.15M-15.37M-9.78M-2.76M-1.47M-6.53M-5.42M-6.55M-13.63M-9.38M-11.68M-17.05M-21.84M-16.23M-15.74M-17.60M-21.58M-19.58M-19.64M
Net Cash Flow 14.57M32.55M-12.40M-9.78M-2.76M-1.47M-6.50M76.79M-3.16M-13.52M-9.47M-13.52M103.20M1.71M-39.06M-44.40M69.95M-65.84M-11.93M12.19M